Published in Am J Transplant on January 01, 2003
Limitations in the Use of Fluorescein Diacetate/Propidium Iodide (FDA/PI) and Cell Permeable Nucleic Acid Stains for Viability Measurements of Isolated Islets of Langerhans. Curr Trends Biotechnol Pharm (2008) 1.09
Improvement of pancreatic islet cell isolation for transplantation. Proc (Bayl Univ Med Cent) (2007) 0.89
Clinical allogeneic and autologous islet cell transplantation: update. Diabetes Metab J (2011) 0.85
Insulin degradation by acinar cell proteases creates a dysfunctional environment for human islets before/after transplantation: benefits of α-1 antitrypsin treatment. Transplantation (2011) 0.84
Implication of mitochondrial cytoprotection in human islet isolation and transplantation. Biochem Res Int (2012) 0.77
A novel method for the assessment of cellular composition and beta-cell viability in human islet preparations. Am J Transplant (2005) 2.74
Role for Bcl-6 in the generation and maintenance of memory CD8+ T cells. Nat Immunol (2002) 2.20
Rescue purification maximizes the use of human islet preparations for transplantation. Am J Transplant (2005) 2.04
Memory B cells without somatic hypermutation are generated from Bcl6-deficient B cells. Immunity (2002) 1.94
Increased levels of soluble triggering receptor expressed on myeloid cells-1 in patients with acute pancreatitis. Crit Care Med (2008) 1.84
West Nile virus-associated encephalitis in recipients of renal and pancreas transplants: case series and literature review. Clin Infect Dis (2004) 1.84
Bcl6 acts as an amplifier for the generation and proliferative capacity of central memory CD8+ T cells. J Immunol (2004) 1.81
Possibility of islet transplantation from a nonheartbeating donor pancreas resuscitated by the two-layer method. Transplantation (2005) 1.65
Significant increase of serum high-mobility group box chromosomal protein 1 levels in patients with severe acute pancreatitis. Pancreas (2006) 1.58
Serum interleukin-15 level is a useful predictor of the complications and mortality in severe acute pancreatitis. Surgery (2007) 1.47
Interleukin-2 is present in human blood vessels and released in biologically active form by heparanase. Immunol Cell Biol (2011) 1.45
Blockade of high mobility group box-1 protein attenuates experimental severe acute pancreatitis. World J Gastroenterol (2006) 1.44
Mesenchymal stem cells suppress B-cell terminal differentiation. Exp Hematol (2009) 1.25
Inhibition of p38 pathway suppresses human islet production of pro-inflammatory cytokines and improves islet graft function. Am J Transplant (2005) 1.24
Identification and activation of Src family kinases in primary megakaryocytes. Exp Hematol (2003) 1.22
Selection of pancreaticojejunostomy techniques according to pancreatic texture and duct size. Arch Surg (2002) 1.18
Continuous measurement of oxygen consumption by pancreatic islets. Diabetes Technol Ther (2002) 1.17
Breakdown of intestinal mucosa via accelerated apoptosis increases intestinal permeability in experimental severe acute pancreatitis. J Surg Res (2006) 1.16
Bcl6 is essential for the generation of long-term memory CD4+ T cells. Int Immunol (2007) 1.16
Carcinosarcoma of the gallbladder with chondroid differentiation. J Gastroenterol (2002) 1.15
Significant elevation of serum interleukin-18 levels in patients with acute pancreatitis. J Gastroenterol (2006) 1.12
Enhancement of anti-tumor immunity by high levels of Th1 and Th17 with a combination of dendritic cell fusion hybrids and regulatory T cell depletion in pancreatic cancer. Oncol Rep (2009) 1.11
Expression of receptor for advanced glycation end products (RAGE) and MMP-9 in human pancreatic cancer cells. Hepatogastroenterology (2004) 1.10
Increase of high-mobility group box chromosomal protein 1 in blood and injured organs in experimental severe acute pancreatitis. Pancreas (2007) 1.10
A novel technique of finger-assisted laparoscopic surgery. Am J Surg (2004) 1.07
Adenocarcinoma arising in gastric inverted hyperplastic polyp: a case report and review of the literature. Pathol Res Pract (2006) 1.07
New-onset diabetes after kidney transplantation: an application of 2003 International Guidelines. Transplantation (2005) 1.06
Effect of the two-layer (University of Wisconsin solution-perfluorochemical plus O2) method of pancreas preservation on human islet isolation, as assessed by the Edmonton Isolation Protocol. Transplantation (2002) 1.06
Resection of gallbladder cancer with hepatic metastasis after chemotherapy with gemcitabine. J Hepatobiliary Pancreat Surg (2008) 1.04
Reductive surgery plus percutaneous isolated hepatic perfusion for multiple advanced hepatocellular carcinoma. Ann Surg (2004) 1.03
Gene expression profile of primary human CD34+CD38lo cells differentiating along the megakaryocyte lineage. Exp Hematol (2004) 1.02
Association of VEGF genotype with mRNA level in colorectal adenocarcinomas. Biochem Biophys Res Commun (2004) 1.01
Silymarin protects pancreatic beta-cells against cytokine-mediated toxicity: implication of c-Jun NH2-terminal kinase and janus kinase/signal transducer and activator of transcription pathways. Endocrinology (2004) 1.01
Significance of Akt phosphorylation on tumor growth and vascular endothelial growth factor expression in human gastric carcinoma. Pathobiology (2006) 1.00
Histopathological predictors of regional lymph node metastasis at the invasive front in early colorectal cancer. Histopathology (2011) 0.99
Perfluorocarbon for organ preservation before transplantation. Transplantation (2002) 0.99
Efficacy of the oxygen-charged static two-layer method for short-term pancreas preservation and islet isolation from nonhuman primate and human pancreata. Cell Transplant (2002) 0.99
The receptor tyrosine kinase Ror2 associates with the melanoma-associated antigen (MAGE) family protein Dlxin-1 and regulates its intracellular distribution. J Biol Chem (2003) 0.98
Real-time quantitative polymerase chain reaction for MDR1, MRP1, MRP2, and CYP3A-mRNA levels in Caco-2 cell lines, human duodenal enterocytes, normal colorectal tissues, and colorectal adenocarcinomas. Drug Metab Dispos (2002) 0.97
Enrichment of putative pancreatic progenitor cells from mice by sorting for prominin1 (CD133) and platelet-derived growth factor receptor beta. Stem Cells (2008) 0.97
Pancreatic diabetes in a follow-up survey of chronic pancreatitis in Japan. J Gastroenterol (2007) 0.96
Suppression of human pancreatic carcinoma cell growth and invasion by epigallocatechin-3-gallate. Pancreas (2002) 0.95
Double cancer of gall bladder and bile duct not associated with anomalous junction of the pancreaticobiliary duct system. Jpn J Clin Oncol (2006) 0.95
A large stone detected in Roux-en-Y jejunal limb 20 years after excision of congenital choledochal cyst. Surgery (2006) 0.95
Induction of polyploidization in leukemic cell lines and primary bone marrow by Src kinase inhibitor SU6656. Blood (2005) 0.95
Superior anti-tumor protection and therapeutic efficacy of vaccination with allogeneic and semiallogeneic dendritic cell/tumor cell fusion hybrids for murine colon adenocarcinoma. Cancer Immunol Immunother (2006) 0.94
Gastric and intestinal claudin expression at the invasive front of gastric carcinoma. Cancer Sci (2007) 0.94
Randomized trial of single-dose versus divided-dose rabbit anti-thymocyte globulin induction in renal transplantation: an interim report. Transplantation (2008) 0.92
Laparoscopy-assisted colon resection for mucosa-associated lymphoid tissue (MALT) lymphoma in the cecum. Hepatogastroenterology (2003) 0.92
A MEK inhibitor (U0126) prolongs survival in nude mice bearing human gallbladder cancer cells with K-ras mutation: analysis in a novel orthotopic inoculation model. Int J Oncol (2003) 0.91
Risk factors influencing pancreatic leakage and the mortality after pancreaticoduodenectomy in a medium-volume hospital. Hepatogastroenterology (2002) 0.90
Cronkhite-Canada syndrome presenting as recurrent severe acute pancreatitis. Gastrointest Endosc (2008) 0.90
Influence of pancreas preservation on human islet isolation outcomes: impact of the two-layer method. Transplantation (2004) 0.90
Sitagliptin therapy in kidney transplant recipients with new-onset diabetes after transplantation. Transplantation (2011) 0.90
Family history of cancer in Japanese gastric cancer patients. Gastric Cancer (2007) 0.89
Simple scoring system for the prediction of the prognosis of severe acute pancreatitis. Surgery (2006) 0.89
Pancreaticobronchial fistula associated with chronic pancreatitis: report of a case. Surg Today (2007) 0.88
Abnormal erythroid differentiation in neonatal bcl-6-deficient mice. Exp Hematol (2005) 0.88
Utility of the new Japanese severity score and indications for special therapies in acute pancreatitis. J Gastroenterol (2009) 0.87
Impact of gemcitabine on the survival of patients with stage IV pancreatic cancer. Pancreas (2007) 0.87
Activation of macrophage-associated molecules after brain death in islets. Cell Transplant (2003) 0.87
Human islet transplantation from pancreases with prolonged cold ischemia using additional preservation by the two-layer (UW solution/perfluorochemical) cold-storage method. Transplantation (2002) 0.87
Prognostic significance of S100A4 expression in gallbladder cancer. Int J Oncol (2002) 0.86
Intravenous administration of ghrelin stimulates growth hormone secretion in vagotomized patients as well as normal subjects. Eur J Endocrinol (2004) 0.86
Experimental evaluation of the mechanical strength of stapling techniques. Surg Endosc (2007) 0.86
Three-dimensional reconstruction of biliary tract using spiral computed tomography for laparoscopic cholecystectomy. World J Surg (2002) 0.85
Internal biliary drainage improves decreased number of gut mucosal T lymphocytes and MAdCAM-1 expression in jaundiced rats. Surgery (2004) 0.85
Preservation of the human pancreas before islet isolation using a two-layer (UW solution-perfluorochemical) cold storage method. Transplantation (2002) 0.85
Splenic atrophy in experimental severe acute pancreatitis. Pancreas (2002) 0.85
Vascular endothelial growth factor increases in serum and protects against the organ injuries in severe acute pancreatitis. J Surg Res (2006) 0.85
Resection of the colon simultaneously with pancreaticoduodenectomy for tumors of the pancreas and periampullary region: short-term and long-term results. World J Surg (2004) 0.85
Protective effect of caspase inhibitor on intestinal integrity in experimental severe acute pancreatitis. J Surg Res (2007) 0.85
Role of toll-like receptor 4 in the pathophysiology of severe acute pancreatitis in mice. Surg Today (2007) 0.85
Presumptive serum sickness as a complication of rabbit-derived antithymocyte globulin immunosuppression. Arthritis Rheum (2009) 0.84
Greater early pancreas graft loss in women compared with men after simultaneous pancreas-kidney transplantation. Clin Transplant (2005) 0.84
Predicting factors for survival of patients with unresectable pancreatic cancer: a management guideline. Hepatogastroenterology (2003) 0.84
Inhibitory effect of epigallocatechin-3-gallate on growth and invasion in human biliary tract carcinoma cells. World J Surg (2002) 0.84
Islet transplantation using donors after cardiac death: report of the Japan Islet Transplantation Registry. Transplantation (2010) 0.84
Bcl6-dependent transcriptional repression by BAZF. Biochem Biophys Res Commun (2003) 0.84
Retroperitoneoscopic laparoscopic distal pancreatectomy with spleen salvage. Hepatogastroenterology (2004) 0.84
No mortality among 100 consecutive pancreaticoduodenectomies in a middle-volume center. World J Surg (2005) 0.83
Impact of the two-layer method on the quality of isolated pancreatic islets. Hepatogastroenterology (2006) 0.83
Expression of receptor for advanced glycation end products (RAGE) in human biliary cancer cells. Hepatogastroenterology (2003) 0.83
Evaluation of tumor cell dissociation as a predictive marker of lymph node metastasis in submucosal invasive colorectal carcinoma. Dis Colon Rectum (2005) 0.83
A randomized 2×2 factorial trial, part 1: single-dose rabbit antithymocyte globulin induction may improve renal transplantation outcomes. Transplantation (2015) 0.83
Immunosuppression in patients with severe acute pancreatitis. J Gastroenterol (2006) 0.83
Treatment strategy against infection: clinical outcome of continuous regional arterial infusion, enteral nutrition, and surgery in severe acute pancreatitis. J Gastroenterol (2007) 0.83
Lymphagenesis correlates with expression of vascular endothelial growth factor-C in colorectal cancer. Oncol Rep (2003) 0.83
Rhythmic expression of ROR beta mRNA in the mice suprachiasmatic nucleus. Neurosci Lett (2002) 0.83
Clinical reappraisal of total pancreatectomy for pancreatic disease. Hepatogastroenterology (2009) 0.83
Antithymocyte globulin induction in living donor renal transplant recipients: final report of the TAILOR registry. Transplantation (2012) 0.83
Frequent occurrence of abnormal E-cadherin/beta-catenin protein expression in advanced gallbladder cancers and its association with decreased apoptosis. Oncology (2007) 0.83
Long-term assessments after pancreaticoduodenectomy with pancreatic duct invagination anastomosis. Surg Today (2007) 0.83
Correlation between expression of major histocompatibility complex class I and that of antigen presenting machineries in carcinoma cell lines of the pancreas, biliary tract and colon. Kobe J Med Sci (2006) 0.82
Expression and localization of ecto-nucleotide pyrophosphatase/phosphodiesterase I-3 (E-NPP3/CD203c/PD-I beta/B10/gp130RB13-6) in human colon carcinoma. Int J Mol Med (2003) 0.82
Chemosensitivity assessed by collagen gel droplet embedded culture drug sensitivity test, and MDR1, MRP1, and MRP2 mRNA expression in human colorectal adenocarcinomas. Pharm Res (2004) 0.82